We Are Ampersand Capital Partners.

A Boston-based private equity firm with more than 25 years of experience in healthcare investing.


Accelerating Growth

Ampersand leverages its sector expertise, expansive operating networks, and global presence to support entrepreneurs in building market leading companies. Our unique blend of skills and focused experience has proven beneficial to our portfolio companies time and again.

CASE STUDY

VIRACOR: IBT Laboratories


Home
LATEST NEWS

PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience May 13, 2021 Confluent Medical Announces Strategic Investment in  The Electrospinning Company Confluent Medical Announces Strategic Investment in The Electrospinning Company May 4, 2021 Bioventus Acquires Bioness, Inc. Bioventus Acquires Bioness, Inc. March 30, 2021 Nexelis and JOINN Laboratories sign Letter of Intent entering partnership to support international sponsors in China in the bioanalytical field Nexelis and JOINN Laboratories sign Letter of Intent entering partnership to support international sponsors in China in the bioanalytical field March 30, 2021 Ampersand Invests in Magritek, Leading Supplier of Benchtop NMR Instruments Ampersand Invests in Magritek, Leading Supplier of Benchtop NMR Instruments March 18, 2021